Search

Your search keyword '"Yasumoto, H"' showing total 193 results

Search Constraints

Start Over You searched for: Author "Yasumoto, H" Remove constraint Author: "Yasumoto, H"
193 results on '"Yasumoto, H"'

Search Results

2. Versican is a potential therapeutic target in docetaxel-resistant prostate cancer.

3. Extracellular activation of Wnt signaling through epigenetic dysregulation of Wnt inhibitory factor-1 (Wif-1) is associated with pathogenesis of adrenocortical tumor

5. Dapagliflozin and cardiovascular outcomes in type 2 diabetes

7. Dapagliflozin and Cardiovascular Outcomes in Type 2 Diabetes

14. Efficacy of intravesical Bacillus Calmette-Guérin for subsequent non-muscle invasive bladder cancer after radical nephroureterectomy for upper urinary tract urothelial carcinoma: A propensity score matched analysis with primary bladder cancer

16. 802 Risk stratification by means of the biological age related factors better predicts cancer-specific survival than the chronological age in patients with upper tract urothelial carcinoma (UTUC): A multi-institutional database study

17. 803 Risk stratification model for lymphovascular invasion, pathological T stage, lymph node involvement, and c-reactive protein predicts high-risk patients - who are candidate for adjuvant chemotherapy in upper urinary tract urothelial cancer

21. MP-21.09: Combination of Diffusion-Weighted Imaging (DWI) and Ultrasound Real-Time Tissue Elastography (RTE) can Eliminate the Necessity of Dynamic Contrast-Enhanced (DCE) MRI in the Detection of Prostate Cancer

48. Improved prognosis of de novo metastatic prostate cancer after an introduction of life-prolonging agents for castration-resistant prostate cancer.

49. Complexities of feature-based learning systems, with application to reservoir computing.

50. Second-line Pembrolizumab for Metastatic Urothelial Carcinoma: Differences in Treatment Outcomes According to the Primary Site.

Catalog

Books, media, physical & digital resources